Clinical Trial Update: Naldebain for Pain Control After Bariatric Surgery [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Naldebain in postoperative pain control after bariatric surgery spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bariatric Surgery-associated Conditions
• Obesity
• Pain Chronic
• Pain Postoperative

Drugs mentioned

• Naldebain (dinalbuphine ester)

Snippet

Sponsor: E-DA Hospital | Conditions: Pain, Postoperative, Pain, Chronic | Phase 2, Phase 3 | Status: UNKNOWN